Feedback

Nuclear Medicine and Molecular Imaging

Farrokh Dehdashti, Barry A. Siegel, Amit Singnurkar
Nuclear Medicine and Molecular Imaging is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Key Points

  • Conventional scintigraphy allows for functional assessment of the esophagus and provides information that is complementary to clinical and radiologic evaluation.
  • Radionuclide scintigraphy is an alternative to conventional imaging and esophageal function tests in the assessment of functional esophageal disorders.
  • PET with the glucose analogue FDG is more sensitive than CT for detecting locoregional and distant metastasis in patients with esophageal cancer and is now generally accepted as an important method for staging and restaging of this disease.
  • PET is most useful in detection of occult stage IV cancer and identification of local or distant metastatic sites that are most easily accessible for tissue confirmation.
  • Limitations of PET in cancer detection are poor sensitivity for small volume tumors and inability to differentiate inflammation from cancer.
  • The roles of PET in treatment planning, prognostication, and assessment of therapy are being defined.

Several nuclear imaging techniques are available for evaluation of esophageal disorders. These are most conveniently divided into two categories: conventional scintigraphy, predominantly used for imaging of patients with benign diseases, and positron emission tomography (PET), used for imaging of patients with esophageal cancer.

-- To view the remaining sections of this topic, please or --

Key Points

  • Conventional scintigraphy allows for functional assessment of the esophagus and provides information that is complementary to clinical and radiologic evaluation.
  • Radionuclide scintigraphy is an alternative to conventional imaging and esophageal function tests in the assessment of functional esophageal disorders.
  • PET with the glucose analogue FDG is more sensitive than CT for detecting locoregional and distant metastasis in patients with esophageal cancer and is now generally accepted as an important method for staging and restaging of this disease.
  • PET is most useful in detection of occult stage IV cancer and identification of local or distant metastatic sites that are most easily accessible for tissue confirmation.
  • Limitations of PET in cancer detection are poor sensitivity for small volume tumors and inability to differentiate inflammation from cancer.
  • The roles of PET in treatment planning, prognostication, and assessment of therapy are being defined.

Several nuclear imaging techniques are available for evaluation of esophageal disorders. These are most conveniently divided into two categories: conventional scintigraphy, predominantly used for imaging of patients with benign diseases, and positron emission tomography (PET), used for imaging of patients with esophageal cancer.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: March 2, 2020